---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004180"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-01-29T23:59:59+00:00"
generated_at: "2026-05-27T07:08:07.934417+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions adds Quantum TM, expanding fingerprint drug testing to 10 UK sites

## Summary
- Quantum Traffic Management adopts INBS fingerprint drug screening across 10 UK sites, replacing saliva/urine methods.
- INBS now serves over 400 accounts across 19 countries; plans US market entry in 2025.
- INBS filed FDA 510(k) submission in December 2024 for US clearance.
- Quantum TM's managing director highlights improved efficiency with in-house rapid testing.
- Serves industries including construction, manufacturing, transport, and logistics.

## SEC filing metadata
- accession: 0001493152-25-004180
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-01-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225004180/0001493152-25-004180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225004180/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004180
- JSON: https://secwatch.observer/filing/0001493152-25-004180.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004180.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.